Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Decem ENT Oy
OY
Dissolved
Y-tunnus 3202457-6
C/O Decem Pharma Oy Pakkalankuja 6, 01510
Vantaa
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 2021 · 5 years old
— employees
Share
Finland
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Decem ENT Oy
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
EUR millions
0M
0M
1M
1M
1M
0M
2022
EBITDA
EUR millions
0M
-0M
-1M
-1M
-1M
0M
2022
Income statement
EUR thousands
Item
2022
Revenue
451
Staff expenses
−1
EBITDA
222
Depreciation & amort.
—
EBIT
222
Net financials
0
Profit before tax
222
Tax
44
Net profit
177
Balance sheet
EUR thousands
Item
2022
Total assets
1 096
Equity
1 084
Long-term debt
—
Short-term debt
12
Total debt
12
Financial ratios
5-year trend
EBITDA margin
49.2%
This company
15.8%
Market median
+211% vs market
2022
2022
Equity ratio
98.9%
This company
38.2%
Market median
+159% vs market
2022
2022
Return on equity
16.4%
This company
18.4%
Market median
+11% vs market
2022
2022
Net profit margin
39.4%
This company
8.1%
Market median
+386% vs market
2022
2022
Asset turnover
0.41×
This company
1.12×
Market median
-63% vs market
2022
2022
Debt / equity
0.01×
This company
0.62×
Market median
+98% vs market
2022
2022
Annual reports & filings
Annual report 2022
Filed via PRH / YTJ · Period 2021-11-01 – 2022-11-30
View
PDF
More on Decem ENT Oy
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
